A phase Ib/II trial of granulocyte-macrophage-colony stimulating factor and interleukin-2 for renal cell carcinoma patients with pulmonary metastases: a case of fatal central nervous system thrombosis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples